Smith, M. T. et al. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Env. Health Perspect. 124, 713–721 (2016).
Guyton, K. Z. et al. Application of the key characteristics of carcinogens in cancer hazard identification. Carcinogenesis 39, 614–622 (2018).
Article CAS PubMed PubMed Central Google Scholar
Smith, M. T. et al. The key characteristics of carcinogens: relationship to the hallmarks of cancer, relevant biomarkers, and assays to measure them. Cancer Epidemiol. Biomark. Prev. 29, 1887–1903 (2020).
Atwood, S. T., Lunn, R. M., Garner, S. C. & Jahnke, G. D. New perspectives for cancer hazard evaluation by the report on carcinogens: a case study using read-across methods in the evaluation of haloacetic acids found as water disinfection by-products. Env. Health Perspect. 127, 125003 (2019).
International Agency for Research on Cancer. IARC Monographs on the Identification of Carcinogenic Hazards to Humans: Preamble. IARC monographs.iarc.fr/wp-content/uploads/2019/07/Preamble-2019.pdf (2019).
Reproductive and Cancer Hazard Assessment Branch. Proposition 65: Evidence on the Carcinogenicity of Coumarin. Office of Environmental Health Hazard Assessment oehha.ca.gov/media/downloads/crnr/coumarinhid.pdf (2017).
National Academies of Sciences, Engineering, and Medicine. Using 21st Century Science to Improve Risk-Related Evaluations. NAP nap.nationalacademies.org/read/24635/chapter/1 (2017).
La Merrill, M. A. et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat. Rev. Endocrinol. 16, 45–57 (2020).
Arzuaga, X. et al. Proposed key characteristics of male reproductive toxicants as an approach for organizing and evaluating mechanistic evidence in human health hazard assessments. Env. Health Perspect. 127, 65001 (2019).
Luderer, U. et al. Proposed key characteristics of female reproductive toxicants as an approach for organizing and evaluating mechanistic data in hazard assessment. Env. Health Perspect. 127, 75001 (2019).
Rusyn, I. et al. Key characteristics of human hepatotoxicants as a basis for identification and characterization of the causes of liver toxicity. Hepatology 74, 3486–3496 (2021).
Article CAS PubMed Google Scholar
Lind, L. et al. Key characteristics of cardiovascular toxicants. Env. Health Perspect. 129, 95001 (2021).
Germolec, D. R. et al. Consensus on the key characteristics of immunotoxic agents as a basis for hazard identification. Env. Health Perspect. 130, 105001 (2022).
Heindel, J. J. et al. Obesity II: establishing causal links between chemical exposures and obesity. Biochem. Pharmacol. 199, 115015 (2022).
Article CAS PubMed PubMed Central Google Scholar
Heindel, J. J. et al. Metabolism disrupting chemicals and metabolic disorders. Reprod. Toxicol. 68, 3–33 (2017).
Article CAS PubMed Google Scholar
Heindel, J. J. et al. Parma consensus statement on metabolic disruptors. Environ. Health 14, 54 (2015).
Article PubMed PubMed Central Google Scholar
Kouidhi, S. & Clerget-Froidevaux, M. S. Integrating thyroid hormone signaling in hypothalamic control of metabolism: crosstalk between nuclear receptors. Int. J. Mol. Sci. 19, 2017 (2018).
Article PubMed PubMed Central Google Scholar
Lustig, R. H. et al. Obesity I: overview and molecular and biochemical mechanisms. Biochem. Pharmacol. 199, 115012 (2022).
Article CAS PubMed PubMed Central Google Scholar
McIntyre, R. S., Kwan, A. T. H., Rosenblat, J. D., Teopiz, K. M. & Mansur, R. B. Psychotropic drug-related weight gain and its treatment. Am. J. Psychiatry 181, 26–38 (2024).
Newbold, R. R., Padilla-Banks, E. & Jefferson, W. N. Environmental estrogens and obesity. Mol. Cell. Endocrinol. 304, 84–89 (2009).
Article CAS PubMed PubMed Central Google Scholar
Solmi, M. et al. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 19, 214–232 (2020).
Article PubMed PubMed Central Google Scholar
Stienstra, R., Tack, C. J., Kanneganti, T. D., Joosten, L. A. & Netea, M. G. The inflammasome puts obesity in the danger zone. Cell Metab. 15, 10–18 (2012).
Article CAS PubMed Google Scholar
Mantovani, A. Plasma trans-fatty acid and risk of nonalcoholic fatty liver disease: new data from National Health and Nutrition Examination Survey (NHANES). Int. J. Cardiol. 272, 329–330 (2018).
Eckard, A. R. & McComsey, G. A. Weight gain and integrase inhibitors. Curr. Opin. Infect. Dis. 33, 10–19 (2020).
Article PubMed PubMed Central Google Scholar
Shang, Q. et al. Serological data analyses show that adenovirus 36 infection is associated with obesity: a meta-analysis involving 5739 subjects. Obesity 22, 895–900 (2014).
Ogilvie, R. P. & Patel, S. R. The epidemiology of sleep and obesity. Sleep. Health 3, 383–388 (2017).
Article PubMed PubMed Central Google Scholar
Huang, W., Ramsey, K. M., Marcheva, B. & Bass, J. Circadian rhythms, sleep, and metabolism. J. Clin. Invest. 121, 2133–2141 (2011).
Article CAS PubMed PubMed Central Google Scholar
Esser, N., Utzschneider, K. M. & Kahn, S. E. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia 63, 2007–2021 (2020).
Bodin, J. et al. Transmaternal bisphenol A exposure accelerates diabetes type 1 development in NOD mice. Toxicol. Sci. 137, 311–323 (2014).
Article CAS PubMed Google Scholar
Bodin, J. et al. Exposure to bisphenol A, but not phthalates, increases spontaneous diabetes type 1 development in NOD mice. Toxicol. Rep. 2, 99–110 (2015).
Article CAS PubMed PubMed Central Google Scholar
Sako, Y. & Grill, V. E. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127, 1580–1589 (1990).
Article CAS PubMed Google Scholar
Zhou, Y. P. & Grill, V. E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93, 870–876 (1994).
Article CAS PubMed PubMed Central Google Scholar
U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44, 1249–1258 (1995).
Kahn, S. E. et al. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes 60, 1552–1560 (2011).
Article CAS PubMed PubMed Central Google Scholar
Kurita, H. et al. Aryl hydrocarbon receptor-mediated effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on glucose-stimulated insulin secretion in mice. J. Appl. Toxicol. 29, 689–694 (2009).
留言 (0)